CompletedPhase 3NCT00088452
Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
Studying Epilepsy syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Principal Investigator
- Tracy A. Glauser, MDChildren's Hospital Medical Center, Cincinnati
- Intervention
- Ethosuximide(drug)
- Enrollment
- 453 enrolled
- Eligibility
- 13 years · All sexes
- Timeline
- 2004 – 2016
Study locations (30)
- The Children's Hospital of Alabama, Birmingham, Alabama, United States
- St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
- Arkansas Children's Hospital, Little Rock, Arkansas, United States
- University of California at San Diego, La Jolla, California, United States
- Mattel Children's Hospital at UCLA, Los Angeles, California, United States
- Children's Hospital of Denver, Denver, Colorado, United States
- Yale University School of Medicine, New Haven, Connecticut, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Nemours Children's Clinic, Jacksonville, Florida, United States
- Miami Children's Hospital, Miami, Florida, United States
- Children's Healthcare of Atlanta, Atlanta, Georgia, United States
- Children's Memorial Hospital, Chicago, Illinois, United States
- Children's Hospital of Michigan, Detroit, Michigan, United States
- Washington University in St. Louis, St Louis, Missouri, United States
- Women and Children's Hospital of Buffalo, Buffalo, New York, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00088452 on ClinicalTrials.govOther trials for Epilepsy syndrome
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07555171EEG Dynamics in Lennox-Gastaut Syndrome Patients Undergoing Fenfluramine TreatmentUniversity of Chicago
- RECRUITINGPHASE1, PHASE2NCT07531745ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet SyndromeIonis Pharmaceuticals, Inc.
- RECRUITINGPHASE3NCT07234695LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down SyndromeFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- RECRUITINGNCT06967727Registry and Natural History of Epilepsy-Dyskinesia SyndromesBoston Children's Hospital
- RECRUITINGNCT07202494Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy AgingAssistance Publique Hopitaux De Marseille
- RECRUITINGNCT05524493High-field MR Imaging in Migraine, Visual Snow and EpilepsyUniversity of Zurich
- RECRUITINGNANCT06847152Spatial Memory and Temporal Lobe EpilepsyCentre Hospitalier Metropole Savoie
- RECRUITINGNANCT06813612Effect of Cognitive Behavioral Play Intervention and EpilepsyIRCCS National Neurological Institute "C. Mondino" Foundation